Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Cytopenia
Interventions
BIOLOGICAL

"Sequential infusion of allogeneic mesenchymal stem cells expanded in vitro"

Trial Locations (1)

37007

University Clinical Hospital of Salamanca, Salamanca

All Listed Sponsors
collaborator

University of Navarrra Hospital (Clinica Universitaria)

OTHER

collaborator

Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán

OTHER

collaborator

Hospitales Universitarios Virgen del Rocío

OTHER

collaborator

Spanish National Health System

OTHER

lead

Red de Terapia Celular

INDUSTRY

NCT02104440 - Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro | Biotech Hunter | Biotech Hunter